IP Library Granted Patent US 8,728,059
Granted Patent B2
US 8,728,059 · App. 11/541,302 · Granted May 20, 2014

System and method for assuring validity of monitoring parameter in combination with a therapeutic device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,728,059
App. No.
11/541,302
Granted
May 20, 2014
Kind
B2
Abstract

The disclosed embodiments relate to a system and method for assuring validity of monitoring parameters in combination with a therapeutic device. An exemplary embodiment of the present technique comprises perturbing a treatment administered to a patient, measuring at least one parameter of the patient reflecting the underlying physiological state and associated with the treatment, and comparing the perturbations of the treatment to measurements of the at least one parameter to determine if the perturbations to the treatment are reflected by the parameter.

Claims (19)

1. A method comprising:

administering a treatment non-invasively at a specified level to a patient;

after administration of the treatment has begun and while continuing to provide some level of treatment, temporarily increasing or decreasing the treatment relative to the specified level and returning to the specified level after the temporary increase or decrease, wherein the temporary increase or decrease in the treatment is initiated independently of a change in a parameter indicative of the underlying physiological state of the patient associated with the treatment;

non-invasively measuring the parameter associated with the treatment;

evaluating the measured parameter value to determine whether the temporary increase or decrease in the treatment is correlated with the measured parameter value; and

providing a notification when the temporary increase or decrease in the treatment is not correlated with the measured parameter value within a predetermined period of time after initiation of the temporary increase or decrease; and

providing a notification that the treatment is being delivered when the temporary increase or decrease in the treatment is correlated with the measured parameter value.

2. The method, as set forth by claim 1 , comprising temporarily increasing or decreasing the treatment periodically over time.

3. The method, as set forth by claim 1 , comprising increasing or decreasing the treatment aperiodically over time.

4. The method, as set forth by claim 1 , wherein the temporary increase or decrease of the treatment is distinguished from a naturally occurring physiological process.

5. The method, set forth by claim 1 , wherein the administered treatment comprises oxygen, airway pressure, insulin, heat, a cardioactive drug, a vasoactive drug, an anesthetic drug, and/or an antipyretic drug.

6. The method, set forth by claim 1 , wherein the parameter comprises oxygen saturation, heart rate, blood pressure, blood flow, cardiac output, and/or blood perfusion.

7. The method, set forth by claim 1 , wherein evaluating the measured parameter value comprises comparing waveforms correlating with the temporary increase or decrease in the administered treatment with waveforms correlating with changes in the parameter or with another measurement or calculation made by a non-invasive monitoring device.

8. The method, set forth by claim 1 , comprising alerting a clinician if the temporary increase or decrease in the treatment is not correlated with the parameter.

9. The method, set forth by claim 1 , comprising automatically adjusting the treatment if the temporary increase or decrease in the treatment is not correlated with the parameter.

10. The method, set forth by claim 1 , comprising automatically adjusting the treatment if the temporary increase or decrease in the treatment is correlated with the parameter.

11. The method, set forth by claim 1 , comprising reverting to a prior or predetermined treatment level if the temporary increase or decrease in the treatment is not correlated with the parameter.

12. The method, set forth by claim 1 , wherein the notification comprises a message on a display.

13. The method, set forth by claim 1 , wherein the notification comprises an audible alarm.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2012
From: NELLCOR PURITAN BENNETT LLC
To: COVIDIEN LP
Reel/Frame 029346/0724 →
CHANGE OF NAME Recorded Mar 15, 2012
From: NELLCOR PURITAN BENNETT INCORPORATED
To: NELLCOR PURITAN BENNETT LLC
Reel/Frame 027873/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2006
From: KARST, EDWARD; BAKER, JR., CLARK R.
To: NELLCOR PURITAN BENNETT INCORPORATED
Reel/Frame 018719/0377 →